| Literature DB >> 25458845 |
Gintautas Tamulaitis1, Migle Kazlauskiene1, Elena Manakova1, Česlovas Venclovas2, Alison O Nwokeoji3, Mark J Dickman3, Philippe Horvath4, Virginijus Siksnys5.
Abstract
Immunity against viruses and plasmids provided by CRISPR-Cas systems relies on a ribonucleoprotein effector complex that triggers the degradation of invasive nucleic acids (NA). Effector complexes of type I (Cascade) and II (Cas9-dual RNA) target foreign DNA. Intriguingly, the genetic evidence suggests that the type III-A Csm complex targets DNA, whereas biochemical data show that the type III-B Cmr complex cleaves RNA. Here we aimed to investigate NA specificity and mechanism of CRISPR interference for the Streptococcus thermophilus Csm (III-A) complex (StCsm). When expressed in Escherichia coli, two complexes of different stoichiometry copurified with 40 and 72 nt crRNA species, respectively. Both complexes targeted RNA and generated multiple cuts at 6 nt intervals. The Csm3 protein, present in multiple copies in both Csm complexes, acts as endoribonuclease. In the heterologous E. coli host, StCsm restricts MS2 RNA phage in a Csm3 nuclease-dependent manner. Thus, our results demonstrate that the type III-A StCsm complex guided by crRNA targets RNA and not DNA.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25458845 DOI: 10.1016/j.molcel.2014.09.027
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970